Cell surface activation of the alternative complement pathway by the fusion protein of measles virus
Open Access
- 1 June 2004
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 85 (6), 1665-1673
- https://doi.org/10.1099/vir.0.79880-0
Abstract
Measles virus (MV)-infected cells are activators of the alternative human complement pathway, resulting in high deposition of C3b on the cell surface. Activation was observed independent of whether CD46 was used as a cellular receptor and did not correlate with CD46 down-regulation. The virus itself was an activator of the alternative pathway and was covered by C3b/C3bi, resulting in some loss in infectivity without loss of virus binding to target cells. The cell surface expression of MV fusion (F), but not haemagglutinin, envelope protein resulted in complement activation of the Factor B-dependent alternative pathway in a dose-dependent manner and F–C3b complexes were formed. The underlying activation mechanism was not related to any decrease in cell surface expression of the complement regulators CD46 and CD55. The C3b/C3bi coating of MV-infected cells and virus should ensure enhanced targeting of MV antigens to the immune system, through binding to complement receptors.Keywords
This publication has 49 references indexed in Scilit:
- Critical Role of Complement and Viral Evasion of Complement in Acute, Persistent, and Latent γ-Herpesvirus InfectionImmunity, 2002
- Human and rodent decay‐accelerating factors (CD55) are not species restricted in their complement‐inhibiting activitiesImmunology, 2000
- Control of C3b and C5b deposition by CD46 (membrane cofactor protein) after alternative but not classical complement activationEuropean Journal of Immunology, 1999
- HIV and human complement: mechanisms of interaction and biological implicationImmunology Today, 1993
- Measles virus haemagglutinin induces down-regulation of gp57/67, a molecule involved in virus bindingJournal of General Virology, 1993
- Complement Activation by gp160 Glycoprotein of HIV-1AIDS Research and Human Retroviruses, 1993
- Membrane Cofactor Protein (MCP or CD46): Newest Member of the Regulators of Complement Activation Gene ClusterAnnual Review of Immunology, 1991
- Complement alternative pathway activation and control on membranes of human lymphoid B cell linesEuropean Journal of Immunology, 1990
- HIV and HIV-infected cells differentially activate the human complement system independent of antibodyImmunology Letters, 1989
- Cellular immune responses during complicated and uncomplicated measles virus infections of manClinical Immunology and Immunopathology, 1984